Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)

SHE:001367 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	859.08	1,034	943.75	247.19	205.26	139.91
Trading Asset Securities	170	-	-	-	0.74	-
Cash & Short-Term Investments	1,029	1,034	943.75	247.19	206	139.91
Cash Growth	8.12%	9.61%	281.79%	19.99%	47.24%	1.68%
Accounts Receivable	78.36	89.2	57.73	47.3	44.61	39.62
Other Receivables	15.61	15.17	14.94	0.04	2.81	0.35
Receivables	93.97	104.38	72.67	47.34	47.42	39.97
Inventory	115.77	115.48	159.31	142.65	104.94	86.18
Other Current Assets	4.23	3.29	2.25	9.01	2.39	0.89
Total Current Assets	1,243	1,258	1,178	446.19	360.75	266.94
Property, Plant & Equipment	208.58	201.51	134.9	85.64	85.89	64.54
Other Intangible Assets	19.94	20.14	19.78	19.74	20.26	18.15
Long-Term Deferred Tax Assets	-	-	-	1.79	1.37	0.87
Long-Term Deferred Charges	0.18	0.27	0.26	1.8	3.27	5
Other Long-Term Assets	34.18	6.45	8.04	10.45	5.76	7.89
Total Assets	1,506	1,486	1,341	565.6	477.31	363.39
Accounts Payable	49.06	52.16	46.55	34.94	56.28	31.43
Accrued Expenses	8.1	18.21	15.65	14.73	14.97	13.64
Current Portion of Leases	1.14	1.14	0.07	0.78	0.75	-
Current Income Taxes Payable	9.61	9.58	6.05	21.61	11.33	9.73
Current Unearned Revenue	8.06	7.92	4.16	7.08	9.49	5.71
Other Current Liabilities	30.76	33.04	6.3	4.26	10.04	16.61
Total Current Liabilities	106.72	122.04	78.77	83.4	102.86	77.13
Long-Term Leases	7.07	6.98	0.1	-	0.78	-
Long-Term Unearned Revenue	5.11	5.39	5.85	6.22	5.59	3.08
Long-Term Deferred Tax Liabilities	6.49	7.43	6.89	6.7	6.78	4.22
Other Long-Term Liabilities	-	-	-	0.24	-	-
Total Liabilities	125.39	141.84	91.62	96.57	116.02	84.42
Common Stock	102.65	102.65	68	51	51	51
Additional Paid-In Capital	764.74	759.97	763.02	104.3	104.3	104.3
Retained Earnings	536.84	505.63	417.07	312.4	204.88	122.31
Treasury Stock	-25.46	-25.46	-	-	-	-
Comprehensive Income & Other	1.77	1.37	1.25	1.33	1.11	1.35
Shareholders' Equity	1,381	1,344	1,249	469.03	361.29	278.96
Total Liabilities & Equity	1,506	1,486	1,341	565.6	477.31	363.39
Total Debt	8.2	8.12	0.17	0.78	1.53	-
Net Cash (Debt)	1,021	1,026	943.59	246.41	204.47	139.91
Net Cash Growth	8.27%	8.77%	282.94%	20.51%	46.15%	1.68%
Net Cash Per Share	6.76	6.85	6.88	2.21	1.83	1.25
Filing Date Shares Outstanding	148.95	148.95	148.95	111.71	111.71	111.71
Total Common Shares Outstanding	148.95	148.95	148.95	111.71	111.71	111.71
Working Capital	1,136	1,136	1,099	362.78	257.89	189.82
Book Value Per Share	9.27	9.02	8.39	4.20	3.23	2.50
Tangible Book Value	1,361	1,324	1,230	449.29	341.03	260.82
Tangible Book Value Per Share	9.13	8.89	8.25	4.02	3.05	2.33
Buildings	-	59.66	55.1	52.99	53.03	38.13
Machinery	-	149.06	123.92	107.08	106.47	88.32
Construction In Progress	-	73.59	48.05	8.41	0.93	6.19

Updated Oct 17, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.